The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jun 12
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jun 12
SANDOZ has announced the listing of the first aflibercept biosimilar, AFQLIR, on the Pharmaceutical Benefits Scheme (PBS), improving access to ophthalmology treatments for Australians living with multiple neovascular-related conditions.
THE Cancer Council NSW and the University of NSW (UNSW) have entered into a $40 million, 10-year partnership to launch a cancer survivorship centre this Thu.
GHB-RELATED deaths have increased 10-fold since 2013, while the number of hospitalisations more than tripled, according to an Australian-first study from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney.
FREE Pharmacy Daily subscription - never miss another story!
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.